Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability
more »
- The Scripps Research Inst., La Jolla, CA (United States)
- Univ. of Southampton (United Kingdom)
- National Inst. of Health (NIH), Bethesda, MD (United States)
- Karolinska Inst., Stockholm (Sweden)
- Fred Hutchinson Cancer Research Center, Seattle, WA (United States)
The elicitation of broadly neutralizing antibodies (bNAbs) against the HIV-1 envelope glycoprotein (Env) trimer remains a major vaccine challenge. Most cross-conserved protein determinants are occluded by self-N-glycan shielding, limiting B cell recognition of the underlying polypeptide surface. The exceptions to the contiguous glycan shield include the conserved receptor CD4 binding site (CD4bs) and glycoprotein (gp)41 elements proximal to the furin cleavage site. Accordingly, we performed heterologous trimer-liposome prime:boosting in rabbits to drive B cells specific for cross-conserved sites. To preferentially expose the CD4bs to B cells, we eliminated proximal N-glycans while maintaining the native-like state of the cleavage-independent NFL trimers, followed by gradual N-glycan restoration coupled with heterologous boosting. This approach successfully elicited CD4bs-directed, cross-neutralizing Abs, including one targeting a unique glycan-protein epitope and a bNAb (87% breadth) directed to the gp120:gp41 interface, both resolved by high-resolution cryoelectron microscopy. This study provides proof-of-principle immunogenicity toward eliciting bNAbs by vaccination.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; NIH; Scripps CHAVI-ID; USDOE Office of Science (SC)
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1577147
- Journal Information:
- Immunity, Journal Name: Immunity Journal Issue: 5 Vol. 51; ISSN 1074-7613
- Publisher:
- Cell PressCopyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer
Hitting the sweet spot: exploiting HIV-1 glycan shield for induction of broadly neutralizing antibodies
Journal Article
·
Tue May 15 20:00:00 EDT 2018
· Nature Communications
·
OSTI ID:1502220
Hitting the sweet spot: exploiting HIV-1 glycan shield for induction of broadly neutralizing antibodies
Journal Article
·
Fri Jul 24 20:00:00 EDT 2020
· Current Opinion in HIV and AIDS
·
OSTI ID:1756809